Wishing you all the joys of the season! 
Asia Pacific Eye Drops Market Forecast to 2030
Asia Pacific Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Initiatives for Eye Care Fuels Asia Pacific Eye Drops Market
In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments.
Sightsavers—an international nongovernmental organization—works in developing countries to treat and prevent eye diseases. A large population in India resides in rural areas with limited or no awareness of eye ailments. Sightsavers aims to create awareness with its Rural Eye Health Programme, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. In addition, in 2019, the WHO launched the Universal Health Coverage and Eye Care: Promoting Country Action, an event to provide practical, step-by-step guidance to support Member States of WHO in planning and implementing the recommendations of the WHO’s World Report on vision. The WHO launched this event to provide integrated people-centered eye care services. Further, the India–US Collaborative Vision Research Program 2020 focuses on advancing science and technology crucial to understand, prevent, and treat blinding eye diseases, visual disorders, and associated complications. The Indian Department of Biotechnology and the US NEI fund this research program.
In December 2021, NIH-funded projects supported the partnership between Kellogg Eye Center and Aravind Eye Hospital (India) to develop a clinical research training program for eyecare specialists. Such training programs are meant to develop the eyecare field in India. Thus, increasing funds for eyecare research will likely offer growth opportunities to the eye drop market players.
Asia Pacific Eye Drops Market Overview
The Asia Pacific eye drops market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR during the forecast period. The growth of the market in Asia Pacific is attributed to the growing prevalence of dry eye diseases in countries such as Australia, and India. Additionally, the growing geriatric population, developing healthcare infrastructure, and increasing investments to boost research activities are projected to drive the Asia Pacific eye drops market during the forecast period. In China, every year about 20–30% of people are diagnosed with dry eye conditions. Major factors causing dry eye condition include long spending hours in front of computers, laptops, and mobile phones. Moreover, high air pollution level is another leading cause of dry eye condition in the country. The country records the highest incidences of diabetes and glaucoma in Asia Pacific, which may lead to a dry eye condition. China is also the largest market for API manufacturing and generic pharmaceuticals. Various companies in the country are involved in the production of ophthalmic products. In April 2023, Ocumension Therapeutics submitted a new drug application (NDA) for approval to commercialize Zerviate 0.24% (cetirizine) ophthalmic solution in China. This solution is majorly used to reduce ocular itching associated with allergic conjunctivitis.
The Asia Pacific eye drops market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. A few of the well-known domestic eye drop brands in the country are Santen, Novartis, Alcon, Allergan, and Baush + Lomb, which offer a range of eye care products, including prescription-based eye drops and over the counter (OTC) solutions. The distribution channels for eye drops in China include hospitals, clinics, pharmacies, and e-commerce platforms. Hospitals and clinics are commonly preferred as distributors by companies offering prescription-based eye drops, while OTC eye drops are readily available in pharmacies and online platforms.
Asia Pacific Eye Drops Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Eye Drops Market Segmentation
The Asia Pacific eye drops market is segmented into type, application, purchase mode, and country.
Based on type, the Asia Pacific eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Asia Pacific eye drops market in 2022.
Based on application, the Asia Pacific eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Asia Pacific eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the Asia Pacific eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Asia Pacific eye drops market in 2022.
Based on country, the Asia Pacific eye drops market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific eye drops market in 2022.
AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Biomedica Pvt Ltd, Pfizer Inc, Prestige Consumer Healthcare Inc., and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the Asia Pacific eye drops market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Research, the Asia Pacific eye drops market was valued at US$ 2,823.84 million in 2022 and is expected to reach US$ 4,386.59 million by 2030, registering a CAGR of 5.7% from 2022 to 2030. Rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the critical factors attributed to the Asia Pacific eye drops market expansion.
Weakening of eye vision is prominently caused by aging. According to the World Health Organization’s World Vision Report, with an aging global population, vision impairment has risen to the forefront as a significant public health concern. In 2020, 11 billion people had uncorrected presbyopia or distance vision impairment. This amount is predicted to rise to 18 billion by 2050. Cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and presbyopia are common causes of vision impairment that occur more frequently in later life (>60 years). Although, over the last 30 years, the age-standardized prevalence of vision impairment and blindness has reduced, this decrease has been offset by a rapidly aging population, resulting in a surging number of individuals with blindness and vision impairment globally, primarily adults over the age of 60. Thus, the high prevalence of eye disease among the older population is likely to encourage manufacturers to introduce new eye care products in the market, which, in turn, will contribute to the growth of the market. Also, the development in the healthcare industry has increased life expectancy. Various healthcare companies design products focusing on the geriatric population. Countries worldwide are adopting new techniques to treat older people safely and effectively. Thus, the growing aging population is driving the growth of the market.
On the contrary, Product recalls hamper the Asia Pacific eye drops market.
Based on type, the Asia Pacific eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held 38.6% share of Asia Pacific eye drops market in 2022, amassing US$ 1,089.95 million. It is projected to garner US$ 1,724.95 million by 2030 to expand at 5.9% CAGR during 2022–2030.
Based on application, the Asia Pacific eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held 64.3% share of Asia Pacific eye drops market in 2022, amassing US$ 1,816.52 million. It is projected to garner US$ 2,794.96 million by 2030 to expand at 5.5% CAGR during 2022–2030. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the Asia Pacific eye drops market is segmented into OTC and prescription. The prescription segment held 59.3% share of Asia Pacific eye drops market in 2022, amassing US$ 1,675.81 million. It is projected to garner US$ 2,663.15 million by 2030 to expand at 6.0% CAGR during 2022–2030.
Based on country, the Asia Pacific eye drops market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.5% share of Asia Pacific eye drops market in 2022. It was assessed at US$ 833.31 million in 2022 and is likely to hit US$ 1,327.38 million by 2030, exhibiting a CAGR of 6.0% during 2022–2030.
Key players operating in the Asia Pacific eye drops market are AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Biomedica Pvt Ltd, Pfizer Inc, Prestige Consumer Healthcare Inc., and Rohto Pharmaceutical Co Ltd, among others.
In May 2023, Bausch + Lomb Corporation received FDA Approval for MIEBO (perfluorohexyloctane ophthalmic solution; formerly known as NOV03), for the treatment of the signs and symptoms of dry eye disease (DED). MIEBO is the first and only FDA-approved treatment for DED that directly targets tear evaporation.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Eye Drops Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. Asia Pacific Eye Drops Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
5.4.1 Changing Lifestyle
5.5 Impact Analysis
6. Eye Drops Market – Asia Pacific Market Analysis
6.1 Asia Pacific Eye Drops Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Asia Pacific Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
7.4.1 Overview
7.4.2 Artificial Tears: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
7.5.1 Overview
7.5.2 Hormones: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
8.3.1 Overview
8.3.2 Eye Diseases: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Dry Eye
8.3.2.1.1 Overview
8.3.2.2 Dry Eye: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Glaucoma
8.3.2.3.1 Overview
8.3.2.3.2 Glaucoma: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Cataract
8.3.2.4.1 Overview
8.3.2.4.2 Cataract: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
8.4.1 Overview
8.4.2 Eye Care: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – by Purchase Mode
9.1 Overview
9.2 Asia Pacific Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
9.3.1 Overview
9.3.2 Prescription: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
9.4.1 Overview
9.4.2 OTC: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Asia Pacific Eye Drops Market
10.1.1 Overview
10.1.2 Asia Pacific Eye Drops Market, by Country, 2022 & 2030 (%)
10.1.2.1 China: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 China: Asia Pacific Eye Drops Market, by Drug Class, 2020–2030 (US$ Million)
10.1.2.1.4 China: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.4.1 China: Asia Pacific Eye Drops Market, by Eye Disease, 2020–2030 (US$ Million)
10.1.2.1.5 China: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.2 Japan: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.4.1 Japan: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.3 India: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 India: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.3.4 India: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.4.1 India: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.3.5 India: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.4 Australia: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Australia: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.4.4 Australia: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.4.1 Australia: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.4.5 Australia: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.5 South Korea: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 South Korea: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.5.4 South Korea: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.5.4.1 South Korea: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.5.5 South Korea: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Eye Diseases, 2020–2030 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
11. Asia Pacific Eye Drops Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Alcon AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AbbVie Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bausch & Lomb Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1.            Asia Pacific Eye Drops Market Segmentation
Table 2.            List of Vendors
Table 3.            China: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 4.            China: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5.            China: Asia Pacific Eye Drops Market, by Eye Disease – Revenue and Forecast to 2030 (US$ Million)
Table 6.            China: Asia Pacific Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 7.            Japan: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 8.            Japan: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9.            Japan: Asia Pacific Eye Drops Market, by Eye Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 10.         Japan: Asia Pacific Eye Drops Market, by Purchase Mode– Revenue and Forecast to 2030 (US$ Million)
Table 11.         India: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 12.         India: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13.         India: Asia Pacific Eye Drops Market, by Eye Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 14.         India: Asia Pacific Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 15.         Australia: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 16.         Australia: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17.         Australia: Asia Pacific Eye Drops Market, by Eye Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 18.         Australia: Asia Pacific Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 19.         South Korea: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 20.         South Korea: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21.         South Korea: Asia Pacific Eye Drops Market, by Eye Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 22.         South Korea: Asia Pacific Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 23.         Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 24.         Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25.         Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Eye Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 26.         Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Purchase Mode– Revenue and Forecast to 2030 (US$ Million)
Table 27.         Organic Developments in the Eye Drops Market
Table 28.         Inorganic Developments in the Eye drop Market
Table 29.         Glossary of Terms, Asia Pacific Eye Drops Market
Â
Â
LIST OF FIGURES
Figure 1.          Asia Pacific Eye Drops Market Segmentation, By Country
Figure 2.          Asia Pacific – PEST Analysis
Figure 3.          Pipeline Analysis
Figure 4.          Asia Pacific Eye Drops Market: Key Industry Dynamics
Figure 5.          Asia Pacific Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6.          Asia Pacific Eye Drops Market Revenue (US$ Mn), 2020 – 2030
Figure 7.          Asia Pacific Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8.          Antibiotics: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9.          Artificial Tears: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10.       Hormones: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11.       Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12.       Asia Pacific Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13.       Eye Diseases: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14.       Dry Eye: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15.       Glaucoma: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16.       Cataract: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17.       Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18.       Eye Care: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19.       Others: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.       Asia Pacific Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21.       Prescription: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22.       OTC: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.       Asia Pacific Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24.       Asia Pacific Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25.       China: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26.       Japan: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27.       India: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28.       Australia: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29.       South Korea: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30.       Rest of Asia Pacific: Asia Pacific Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31.       Growth Strategies in the Eye Drops Market (%)
List of Companies
o AbbVie Inc                                                             Â
o Alcon AGÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
o Bausch & Lomb Inc                                              Â
o Biomedica Pvt Ltd                                                Â
o Pfizer Inc                                                               Â
o Prestige Consumer Healthcare Inc.                  Â
o Rohto Pharmaceutical Co Ltd                            Â
You must be logged in to post a review.
Reviews
There are no reviews yet.